Profiles for companies starting with 'j'
✉ Email this page to a colleague
Drugs and US Patents for j
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | ZILXI | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 213690-001 | May 28, 2020 | RX | Yes | Yes | 8,865,139 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Janssen Prods | SYMTUZA | cobicistat; darunavir; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210455-001 | Jul 17, 2018 | RX | Yes | Yes | 8,148,374 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Janssen Pharms | INVOKANA | canagliflozin | TABLET;ORAL | 204042-002 | Mar 29, 2013 | AB | RX | Yes | Yes | 7,943,582*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Jubilant Generics | PREGABALIN | pregabalin | CAPSULE;ORAL | 209530-008 | May 20, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
